Perceptive Xontogeny Venture Fund, LP
- SEC CIK
- 0001757940
No open-market purchases or sales filed in the past year.
Current role at each company
- SLDB Solid Biosciences Inc.Director, 10% Owneras of Feb 21, 2025
- ATXS Astria Therapeutics, Inc.Directoras of Feb 5, 2024
- LABP Landos Biopharma, Inc.10% Owneras of Jan 11, 2023
- LIANY LianBioDirector, 10% Owneras of Aug 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Perceptive Xontogeny Venture Fund, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SLDB Solid Biosciences Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 (view filing)4:17 PM ET | Feb 19 | 2 days | Edelman Joseph and 3 othersDirector, 10% Owner | PPurchase | +5.00M | $4.03 | +$20.1M | +73.2%11.8M after | |
| Jan 12, 2024 (view filing)5:15 PM ET | Jan 11 | 1 day | Edelman Joseph and 3 othersDirector, 10% Owner | PPurchase | +3.41M | $5.53 | +$18.9M | +99.6%6.83M after |
ATXS Astria Therapeutics, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 (view filing)5:02 PM ET | Feb 1 | 4 days | Edelman Joseph and 3 othersDirector | PPurchase | +2.48M | $12.09 | +$30.0M | +103.7%4.87M after | |
| Dec 22, 2023 (view filing)2:51 PM ET | Dec 21 | 1 day | Edelman Joseph and 3 othersDirector | PPurchase | +740.0K | $6.20 | +$4.59M | +44.8%2.39M after | |
| Oct 18, 2023 (view filing)4:11 PM ET | Oct 16 | 2 days | Edelman Joseph and 3 othersDirector | PPurchase | +1.07M | $6.51 | +$7.00M | +200.1%1.61M after | 2 lots |
| Oct 18, 2023 (view filing)4:11 PM ET | Oct 16 | 2 days | Edelman Joseph and 3 othersDirector | PPurchase | +2.42M | $7.86 | +$19.0M | –345.4K after | Derivative4 lots |
| Dec 21, 2022 (view filing)4:52 PM ET | Dec 19 | 2 days | Edelman Joseph and 3 othersDirector | PPurchase | +908.3K | $11.01 | +$10.0M | +698.4%1.04M after |
LABP Landos Biopharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 (view filing)6:45 PM ET | Jan 10 | 1 day | Edelman Joseph and 4 others10% Owner | PPurchase | +30.9M | $0.54 | +$16.7M | –3.64M after | Derivative2 lots |
LIANY LianBio
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 (view filing)9:17 AM ET | Aug 18 | 4 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +998.2K | $2.40 | +$2.40M | +36.6%3.73M after | |
| May 27, 2022 (view filing)10:06 AM ET | May 26 | 1 day | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +69.0K | $3.13 | +$216.0K | +2.6%2.73M after | |
| May 25, 2022 (view filing)6:51 PM ET | May 23-25 | 2 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +171.3K | $2.58 | +$442.4K | +6.9%2.66M after | 3 lots |
| Nov 5, 2021 (view filing)1:47 PM ET | Nov 3 | 2 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchase | +2.27M | $15.98 | +$36.3M | +8.9%27.9M after | 2 lots |
| Nov 3, 2021 (view filing)6:59 PM ET | Nov 1-2 | 2 days | Perceptive Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +220.0K | $14.59 | +$3.21M | +3.1%7.25M after | 2 lots |